Search
for
Sort by
Research 271–300 of 1000+
- Diseases of Periocular Hair
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Nosological profile of dermatological diseases in primary health care and dermatology secondary care in Florianópolis (2016–2017)
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Dermatologic Care of the Transplant Patient
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Cicatricial Alopecia
- Alternative Medicine for Hair Loss
- Psikonöroimmünoloji ve Multifaktöryel Psikodermatolojik Hastalıklar
- Optimizing skin disease diagnosis: harnessing online community data with contrastive learning and clustering techniques
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Spectrum and clinical burden of Unrecognized Dermatologic Diseases in hospitalized adults: A single-centre cross-sectional study
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Coexistence of alopecia areata and fixed drug eruption: An uncommon isotopic phenomenon?
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- A clinical study of pemphigus vulgaris and its variants, evaluation of safety and efficacy of glucocorticoids versus immunosuppressants at tertiary care hospital: a study of 75 cases
- Journal of Population Therapeutics and Clinical Pharmacology
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Ritlecitinib in severe alopecia areata: a profile of its use
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Part Three (Cure Most Diseases by Logical Nutrition Treatment): The Society Agent Simulating (SAS) & Usage of Oral and Dental Diseases to Predict Criminals Earlier
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- THU0189 Safety of four treatment regimens in early rheumatoid arthritis
- Dermatological history and examination
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- A Cross-Sectional Analysis of Psychological and Dermatologic Manifestations Post-February 6 Earthquakes in Dermatology Patients
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Psychosocial Aspects of Skin Conditions and Diseases